GR agonists, such as dexamethasone and prednisolone, are standard treatments for childhood leukemias, typically effective in combination therapies (e.g., with vincristine), though alone they often provide only temporary remission or symptom relief [94]. This evidence concerns the gene NR3C1 and leukemia.